LONDON, July 22 (UPI) -- The Phase 1 clinical trial of the drug abiraterone revealed significant tumor shrinkage in men with advanced prostate cancer, researchers in Britain said.
BOSTON, May 21 (UPI) -- U.S. medical scientists said they've conducted a trial that supports first-line use of targeted therapy to treat lung cancer.
LONDON, Jan. 16 (UPI) -- Two British charities are joining to initiate the first U.K.-based clinical trial for women with a specific aggressive form of breast cancer.
WASHINGTON, June 29 (UPI) -- A survey of 2,000 U.S. cancer survivors found only 12 percent of men were aware of prostate cancer clinical trials at the time of diagnosis.
SAN FRANCISCO, May 22 (UPI) -- A study of more than 75,000 U.S. adults found that taking multivitamins, vitamin C and E and folate does not decrease the risk of lung cancer.
COLUMBUS, Ohio, March 28 (UPI) -- In a preliminary U.S. trial, berries were found to have properties that inhibit cancer in the esophagus, colon and oral cavity.
CAMBRIDGE, Mass., Dec. 21 (UPI) -- A string of recent studies show taking vitamin supplements does not prevent cancer or cardiovascular disease but vitamin E lowers prostate cancer risk.
NEW YORK, Nov. 9 (UPI) -- A Columbia University study has reportedly demonstrated Zyflamend, an proprietary herbal extract preparation, suppresses prostate cancer cell growth.
WASHINGTON, June 30 (UPI) -- The U.S. Preventive Services Task Force Monday concluded there is insufficient evidence to recommend vitamins as a way to prevent cancer or heart disease.
